High density lipoprotein complete list of trials
High Density Lipoprotein Microchapters |
Diagnosis |
---|
Treatment |
Clinical Trials |
Case Studies |
High density lipoprotein complete list of trials On the Web |
American Roentgen Ray Society Images of High density lipoprotein complete list of trials |
High density lipoprotein complete list of trials in the news |
Risk calculators and risk factors for High density lipoprotein complete list of trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]
Reconstituted HDL Infusion
Name of the Trial | Official Name | Status | |
CHI-SQUARE Study | CHI SQUARE: Can HDL Infusions Significantly Quicken Atherosclerosis Regression? A Phase II, Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects With Acute Coronary Syndrome | Ongoing | |
CSL-112 Trial - Phase 1 | An Adaptive, Phase I, Randomised, Placebo-controlled, Sponsor-unblinded, Multiple Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous CSL112 in Healthy Volunteers | Completed | |
CSL-112 Trial - Phase 1 | An Adaptive, Phase I, Single-Centre, Randomised, Double-blind, Placebo-controlled Single Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics, of Intravenous CSL112 in Healthy Volunteers | Completed | |
CSL-112 Trial - Phase 2 | A Phase 2a, Multi-center, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of a Single Intravenous Infusion of CSL112in Patients With Stable Atherothrombotic Disease | Completed | |
ERASE Trial | Regression of Coronary Atherosclerotic Lesions After rHDL Infusions in Acute Coronary Syndrome Patients as Assessed by Intravascular Ultrasound | Completed | |
Infusion of Apo A-1 Milano | A Phase III Study of Microsomal Triglyceride Transfer Protein (MTP) Inhibitor AEGR-733 in Patients With Homozygous Familial Hypercholesterolemia on Current Lipid-lowering Therapy | Completed |
CETP Inhibitors
ACCELERATE Trial | Assessment of Clinical Effects of Cholesteryl Ester Transfer Protein Inhibition With Evacetrapib in Patients at a High-Risk for Vascular Outcomes | Ongoing | |
dal-OUTCOMES Trial | |||
DEFINE Trial | |||
ILLUMINATE Trial | |||
ILLUSTRATE Trial | |||
REVEAL Trial |
Niacin
AIM-HIGH Trial |
ARBITER 2 Trial |
ARBITER 3 Trial |
ARBITER 6-HALTS Trial |
CLAS Trial |
HATS Trial |
Oxford Niaspan Study |
Fibrate
VA-HIT Trial |
BECAIT Trial |
BIP Trial |
Statin
ASTEROID Trial |
SATURN Trial |
4S Trial |
CORONA Trial |
Multiple Lipid Lowering Drugs
HARP Study |
AFREGS Trial |
Other trials
Name of the Trial | Official Name | Status | |
A Study of LY2484595 in Patients With High LDL-C or Low HDL-C | A Phase 2 Efficacy and Safety Study of LY2484595 Alone and in Combination With Atorvastatin, Simvastatin, and Rosuvastatin in Patients With Hypercholesterolemia or Low HDL-C | Completed | |
A Study of LY2484595 in Japanese Subjects | A Phase 2 Dose Response Study of LY2484595 in Japanese Subjects | Completed | |
A Study of LY2484595 on Pharmacokinetics in Healthy Subjects | A Phase 1 Study to Evaluate the Safety and Tolerability of LY2484595 SDSD-PG Tablets and the Effect of CYP3A Inhibition by Ketoconazole on the Pharmacokinetics of LY2484595 in Healthy Subjects | Completed |
|